News CRISPR-Modified Skin Grafts to Treat Addiction? ‘The Opportunities Are Endless,’ Says CEO AddGraft Therapeutics has developed a novel platform that aims to effectively treat substance use disorders with genetically engineered skin grafts – a first-of-its-kind treatment with myriad applications. Developed by University of...
Team Shane Thomas Peace, PhD Manager, Intellectual Property and Technology Development Manager, Intellectual Property and Technology Development
News Mentoring Program to Bridge Gap Between Ideas and Innovation The inaugural event of the new Chicago Innovators Mentors program matched experienced entrepreneurs, executives, and domain experts with innovating faculty from multiple institutions. Left to right: Mentor Dan Schmitt, Jim...
News 2010 BIO: Celebrating Regional Innovation and Biotech’s Future Illinois Governor Pat Quinn visits the Chicago Innovation Pipeline booth at the 2010 BIO Convention held at McCormick Place. The pipeline, developed by UChicagoTech, is a collection of technologies available...
News Making Disc Drives Smaller, Faster, More Stable University Provost Thomas Rosenbaum and Daniel Silevitch, Research Scientist, James Franck Institute, stand inside a shielded room, used to screen out radio interference from outside. To the left is the...
News Ice Slurry Research Pays Off for a Cleaner Environment “Twenty years ago, Argonne and the DOE must have had a crystal ball to develop an environmentally friendly refrigeration system that could meet today’s urgent demand for ‘green’ technologies,” says...
News Cultivating Partners Whether it comes to medical devices, therapeutics or pharmaceuticals, Richard Ganz brings a rich background, widespread knowledge and 30 years of experience to help University of Chicago researchers translate their...
Technology Microbiome-Based Therapeutic For Enhancing Anti-Tumor Immunity In Cancer Treatment Innovative therapeutic strategy leveraging commensal microbiota, specifically by oral administration of Bifidobacterium, to enhance anti-tumor immunity, potentially improving cancer treatment when combined with checkpoint inhibitors Unmet Need: Only 20-40%…
News Reluctant Renaissance Man Even though Olaf Schneewind operates seamlessly in many overlapping scientific, academic and corporate circles, he denies being a Renaissance Man. “I’m just a complete workaholic, 365 days of the year,”...
News Executive-in-Residence Nancy Harvey: Right Place, Right Time Two out of two. That’s how many new business ventures Nancy Harvey has seen come to fruition since she joined UChicagoTech, the University of Chicago’s Office of Technology and Intellectual...
News Given Ventures Back Time. Treasure. Talent. That’s what alumni should give back to their schools, according to Doug Given, an Investment Partner at Bay City Capital and longtime advisor to UChicagoTech—the University of Chicago’s Office...
News Discovery Matters Alan Thomas, Director, UChicagoTech, Ellen Rudnick, Executive Director and Clinical Professor of Entrepreneurship at the Polsky Center, Keith Moffat, Deputy Provost for Research, Donald Levy, Vice President for Research and...
